$2.14 Billion is the total value of Eventide Asset Management's 144 reported holdings in Q1 2018. The portfolio turnover from Q4 2017 to Q1 2018 was 25.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| AIMT | Buy | AIMMUNE THERAPEUTICS INC | $49,813,000 | +7.4% | 1,564,983 | +27.6% | 2.33% | -3.5% |
| SPLK | Buy | SPLUNK INC | $44,571,000 | +62.5% | 453,000 | +36.9% | 2.09% | +46.0% |
| SAGE | Buy | SAGE THERAPEUTICS INC | $40,268,000 | +32.4% | 250,000 | +35.4% | 1.88% | +18.9% |
| INST | Buy | INSTRUCTURE INC | $39,705,000 | +42.5% | 942,000 | +11.9% | 1.86% | +27.9% |
| VRTX | Buy | VERTEX PHARMACEUTICALS INC | $39,604,000 | +46.8% | 243,000 | +35.0% | 1.85% | +31.9% |
| MIC | Buy | MACQUARIE INFRASTRUCTURE COR | $38,112,000 | -19.5% | 1,032,000 | +40.0% | 1.78% | -27.7% |
| HUBS | Buy | HUBSPOT INC | $37,905,000 | +106.2% | 350,000 | +68.3% | 1.78% | +85.1% |
| MGA | Buy | MAGNA INTL INC | $34,852,000 | +0.8% | 618,500 | +1.4% | 1.63% | -9.4% |
| CELG | Buy | CELGENE CORP | $32,205,000 | +12.5% | 361,000 | +31.6% | 1.51% | +1.1% |
| NEP | Buy | NEXTERA ENERGY PARTNERS LP | $32,080,000 | -4.9% | 802,200 | +2.5% | 1.50% | -14.6% |
| STKL | Buy | SUNOPTA INC | $30,534,000 | +1.0% | 4,300,540 | +10.2% | 1.43% | -9.3% |
| SGEN | Buy | SEATTLE GENETICS INC | $29,153,000 | +3.8% | 557,000 | +6.1% | 1.36% | -6.8% |
| VRNS | Buy | VARONIS SYS INC | $28,980,000 | +255.3% | 479,000 | +185.1% | 1.36% | +219.3% |
| FIVN | Buy | FIVE9 INC | $26,632,000 | +85.8% | 894,000 | +55.2% | 1.25% | +66.9% |
| GTTN | Buy | GTT COMMUNICATIONS INC | $25,005,000 | +1161.0% | 441,000 | +943.9% | 1.17% | +1036.9% |
| SNA | Buy | SNAP ON INC | $24,266,000 | -15.3% | 164,470 | +0.1% | 1.14% | -23.9% |
| LII | Buy | LENNOX INTL INC | $24,116,000 | +54.4% | 118,000 | +57.3% | 1.13% | +38.7% |
| JELD | Buy | JELD-WEN HLDG INC | $19,722,000 | -1.1% | 644,100 | +27.2% | 0.92% | -11.2% |
| PANW | Buy | PALO ALTO NETWORKS INC | $18,878,000 | +44.7% | 104,000 | +15.6% | 0.88% | +30.0% |
| CAFD | Buy | 8POINT3 ENERGY PARTNERS LPcl a rpt ltdpt | $18,876,000 | -15.1% | 1,553,600 | +6.3% | 0.88% | -23.7% |
| PEGI | Buy | PATTERN ENERGY GROUP INCcl a | $17,887,000 | -18.8% | 1,034,500 | +1.0% | 0.84% | -27.1% |
| ANET | New | ARISTA NETWORKS INC | $16,850,000 | – | 66,000 | +100.0% | 0.79% | – |
| SRPT | Buy | SAREPTA THERAPEUTICS INC | $16,744,000 | +86.9% | 226,000 | +40.4% | 0.78% | +67.9% |
| APTV | Buy | APTIV PLC | $16,697,000 | +24.6% | 196,500 | +24.4% | 0.78% | +11.9% |
| ROP | New | ROPER TECHNOLOGIES INC | $16,561,000 | – | 59,000 | +100.0% | 0.78% | – |
| AY | Buy | ATLANTICA YIELD PLC | $16,202,000 | -5.2% | 827,500 | +2.7% | 0.76% | -14.8% |
| HASI | Buy | HANNON ARMSTRONG SUST INFR C | $14,118,000 | -15.8% | 724,000 | +3.8% | 0.66% | -24.4% |
| MYOV | Buy | MYOVANT SCIENCES LTD | $12,199,000 | +74.8% | 573,553 | +3.9% | 0.57% | +56.9% |
| ZGNX | Buy | ZOGENIX INC | $10,613,000 | +57.7% | 265,000 | +57.7% | 0.50% | +41.6% |
| PAYC | Buy | PAYCOM SOFTWARE INC | $10,309,000 | +598.0% | 96,000 | +422.3% | 0.48% | +527.3% |
| BHVN | Buy | BIOHAVEN PHARMACTL HLDG CO L | $8,913,000 | +36.5% | 346,000 | +43.0% | 0.42% | +22.6% |
| KALV | Buy | KALVISTA PHARMACEUTICALS INC | $8,532,000 | +23.4% | 900,000 | +26.9% | 0.40% | +10.8% |
| BOLD | Buy | AUDENTES THERAPEUTICS INC | $8,114,000 | +15.4% | 270,000 | +20.0% | 0.38% | +3.5% |
| ARGX | New | ARGENX SEsponsored adr | $8,044,000 | – | 100,000 | +100.0% | 0.38% | – |
| REGN | Buy | REGENERON PHARMACEUTICALS | $7,920,000 | +180.9% | 23,000 | +206.7% | 0.37% | +152.4% |
| QURE | New | UNIQURE NV | $7,873,000 | – | 335,000 | +100.0% | 0.37% | – |
| MYOK | Buy | MYOKARDIA INC | $7,418,000 | +60.2% | 152,000 | +38.2% | 0.35% | +44.0% |
| RCKT | New | ROCKET PHARMACEUTICALS INC | $7,398,000 | – | 394,585 | +100.0% | 0.35% | – |
| MNTA | New | MOMENTA PHARMACEUTICALS INC | $7,260,000 | – | 400,000 | +100.0% | 0.34% | – |
| EXR | Buy | EXTRA SPACE STORAGE INC | $7,251,000 | +1.1% | 83,000 | +1.2% | 0.34% | -9.4% |
| EXAS | Buy | EXACT SCIENCES CORP | $5,283,000 | +0.6% | 131,000 | +31.0% | 0.25% | -9.9% |
| ECYT | New | ENDOCYTE INC | $3,182,000 | – | 350,000 | +100.0% | 0.15% | – |
| BEP | Buy | BROOKFIELD RENEWABLE PARTNERpartnership unit | $3,082,000 | +13.5% | 99,000 | +27.2% | 0.14% | +1.4% |
| SLDB | New | SOLID BIOSCIENCES INC | $3,000,000 | – | 400,000 | +100.0% | 0.14% | – |
| MDGL | New | MADRIGAL PHARMACEUTICALS INC | $2,920,000 | – | 25,000 | +100.0% | 0.14% | – |
| DERM | Buy | DERMIRA INC | $2,669,000 | -22.6% | 334,000 | +169.4% | 0.12% | -30.6% |
| INCY | Buy | INCYTE CORP | $2,583,000 | +1.0% | 31,000 | +14.8% | 0.12% | -9.0% |
| FHB | Buy | FIRST HAWAIIAN INC | $2,463,000 | +15.5% | 88,500 | +21.1% | 0.12% | +3.6% |
| JCI | Buy | JOHNSON CTLS INTL PLC | $2,343,000 | +17.1% | 66,500 | +26.7% | 0.11% | +5.8% |
| ABB | Buy | ABB LTDsponsored adr | $2,255,000 | +11.6% | 95,000 | +26.2% | 0.11% | +1.0% |
| HMC | Buy | HONDA MOTOR LTD | $2,049,000 | +10.6% | 59,000 | +8.6% | 0.10% | -1.0% |
| RARX | New | RA PHARMACEUTICALS INC | $2,060,000 | – | 388,000 | +100.0% | 0.10% | – |
| Buy | ESSA PHARMA INC | $1,831,000 | +217.9% | 9,639,410 | +254.5% | 0.09% | +186.7% | |
| TSM | Buy | TAIWAN SEMICONDUCTOR MFG LTDsponsored adr | $1,816,000 | +18.9% | 41,500 | +7.8% | 0.08% | +6.2% |
| TERP | New | TERRAFORM PWR INC | $1,728,000 | – | 161,000 | +100.0% | 0.08% | – |
| BDN | Buy | BRANDYWINE RLTY TRsh ben int new | $1,644,000 | +10.9% | 103,500 | +27.0% | 0.08% | 0.0% |
| BG | Buy | BUNGE LIMITED | $1,604,000 | +30.6% | 21,700 | +18.6% | 0.08% | +17.2% |
| TNDM | New | TANDEM DIABETES CARE INC | $1,364,000 | – | 275,000 | +100.0% | 0.06% | – |
| ETN | Buy | EATON CORP PLC | $1,358,000 | +35.4% | 17,000 | +33.9% | 0.06% | +23.1% |
| MLHR | Buy | MILLER HERMAN INC | $1,304,000 | +2.7% | 40,800 | +28.7% | 0.06% | -7.6% |
| APU | Buy | AMERIGAS PARTNERS L Punit l p int | $1,279,000 | +10.6% | 32,000 | +28.0% | 0.06% | 0.0% |
| CCIPRA | Buy | CROWN CASTLE INTL CORP NEW6.875% con pfd a | $1,115,000 | +30.9% | 990 | +31.1% | 0.05% | +18.2% |
| CVA | Buy | COVANTA HLDG CORP | $1,066,000 | +54.9% | 73,500 | +80.6% | 0.05% | +38.9% |
| NYLD | Buy | NRG YIELD INCcl c | $1,037,000 | +75.2% | 61,000 | +94.9% | 0.05% | +58.1% |
| WELL | Buy | WELLTOWER INC | $958,000 | +69.9% | 17,600 | +98.9% | 0.04% | +55.2% |
| VTR | Buy | VENTAS INC | $966,000 | +62.6% | 19,500 | +97.0% | 0.04% | +45.2% |
| MNLO | New | MENLO THERAPEUTICS INC | $940,000 | – | 25,000 | +100.0% | 0.04% | – |
| GPMT | New | GRANITE PT MTG TR INC | $918,000 | – | 55,500 | +100.0% | 0.04% | – |
| WBK | Buy | WESTPAC BKG CORPsponsored adr | $887,000 | +6.7% | 40,000 | +17.3% | 0.04% | -2.3% |
| CIG | Buy | COMPANHIA ENERGETICA DE MINAsp adr n-v pfd | $864,000 | +42.1% | 335,000 | +13.6% | 0.04% | +25.0% |
| ERIC | Buy | ERICSSONadr b sek 10 | $736,000 | +15.9% | 115,000 | +21.1% | 0.03% | +3.0% |
| LPT | Buy | LIBERTY PPTY TRsh ben int | $616,000 | +19.4% | 15,500 | +29.2% | 0.03% | +7.4% |
| LXP | Buy | LEXINGTON REALTY TRUST | $630,000 | +18.6% | 80,000 | +45.5% | 0.03% | +3.6% |
| AYI | Buy | ACUITY BRANDS INC | $564,000 | -2.9% | 4,050 | +22.7% | 0.03% | -13.3% |
| New | HERCULES CAPITAL INCdbcv 4.375% 2/0 | $203,000 | – | 200,000 | +100.0% | 0.01% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR/A filed 2018-05-18
About Eventide Asset Management
Eventide Asset Management is a Boston-based investment firm that specializes in providing investment solutions to investors who are looking for long-term growth opportunities. The company was founded in 2008 by a group of experienced investment professionals who shared a common vision of creating a firm that would focus on investing in companies that are making a positive impact on society.
The company's investment philosophy is based on the belief that companies that are making a positive impact on society are more likely to be successful in the long run. Eventide's investment team conducts extensive research to identify companies that are aligned with this philosophy and have the potential to deliver strong returns over the long term.
The company's investment strategies are managed by a team of experienced professionals, including CEO Robin John, COO Finny Kuruvilla, and Chief Investment Officer, Dr. Finny Kuruvilla. The team has a proven track record of delivering strong returns to investors, and their investment strategies have been recognized by industry experts.
Eventide Asset Management offers a range of investment solutions, including mutual funds, separately managed accounts, and exchange-traded funds (ETFs). The company's funds are available to individual investors, financial advisors, and institutional investors.
Overall, Eventide Asset Management is a reputable investment firm that has a strong focus on investing in companies that are making a positive impact on society. The company's experienced investment team and proven track record make it a compelling option for investors who are looking for long-term growth opportunities.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| LOWES COS INC | 40 | Q3 2023 | 3.2% |
| PALO ALTO NETWORKS INC | 40 | Q3 2023 | 3.6% |
| ASML HOLDINGS NV | 40 | Q3 2023 | 1.9% |
| NEUROCRINE BIOSCIENCES INC | 40 | Q3 2023 | 1.1% |
| REPLIGEN CORP | 40 | Q3 2023 | 0.5% |
| VERACYTE INC | 38 | Q3 2023 | 1.5% |
| LAM RESEARCH CORP | 35 | Q3 2023 | 3.4% |
| XPO LOGISTICS INC | 34 | Q1 2023 | 3.8% |
| COLLEGIUM PHARMACEUTICAL INC | 34 | Q3 2023 | 2.6% |
| MAGNA INTL INC | 33 | Q4 2021 | 2.5% |
View Eventide Asset Management's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Cogent Biosciences, Inc. | February 14, 2023 | 2,589,778 | 3.7% |
| ESSA Pharma Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| Freeline Therapeutics Holdings plc | February 14, 2023 | 5,920,765 | 9.1% |
| KnowBe4, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| Praxis Precision Medicines, Inc. | February 14, 2023 | 3,518,062 | 7.5% |
| Prometheus Biosciences, Inc. | February 14, 2023 | 1,032,938 | 2.2% |
| SUTRO BIOPHARMA, INC.Sold out | February 14, 2023 | 0 | 0.0% |
| Vital Farms, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| Zymeworks Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| Entasis Therapeutics Holdings Inc. | February 14, 2022 | 590,602 | 1.2% |
View Eventide Asset Management's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR/A | 2024-02-20 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
View Eventide Asset Management's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.